University of Alabama: Nationwide Study Shows That Only 1 in 3 Individuals With Severe Dyslipidemia Receive Lipid-Lowering Medications
January 24, 2024
January 24, 2024
BIRMINGHAM, Alabama, Jan. 24 (TNSres) -- The University of Alabama issued the following news:
In a collaborative effort led by the University of Alabama at Birmingham Marnix E. Heersink School of Medicine, researchers examining how the evaluation of cholesterol levels, awareness of high cholesterol levels, and lipid-lowering therapy varied between 2011 and 2020 among individuals with severe dyslipidemia found that only one in three individuals with severe dyslipidemia took statins, . . .
In a collaborative effort led by the University of Alabama at Birmingham Marnix E. Heersink School of Medicine, researchers examining how the evaluation of cholesterol levels, awareness of high cholesterol levels, and lipid-lowering therapy varied between 2011 and 2020 among individuals with severe dyslipidemia found that only one in three individuals with severe dyslipidemia took statins, . . .